U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 1162

1.
Cost‐Effectiveness Analysis of Empagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction in the United States
Odette S. Reifsnider, Ali Tafazzoli, Stephan Linden, Jack Ishak, Pal Rakonczai, Matthew Stargardter, Effie Kuti
J Am Heart Assoc. 2024 Feb 20; 13(4): e029042. Published online 2024 Feb 16. doi: 10.1161/JAHA.123.029042
PMCID:
PMC11010075
ArticlePDF–2.1M
2.
Methylphenidate-Induced Non-ischemic Heart Failure With Reduced Ejection Fraction and Mild Pulmonary Hypertension
Derek Ugwendum, Yolande Mbome, Divine Besong Arrey Agbor, Umida Burkhanova, Rita Offor, Ikpechukwu J Okorie, Asher Gorantla, Frances A Amokaye, Muhammed Atere, Jay Nfonoyim
Cureus. 2024 Mar; 16(3): e55604. Published online 2024 Mar 5. doi: 10.7759/cureus.55604
PMCID:
PMC10995454
ArticlePDF–589K
3.
The modified Rajan’s heart failure risk score predicts all-cause mortality in patients hospitalized for heart failure with reduced ejection fraction: a retrospective cohort study
Rajesh Rajan, Jeremy Man Ho Hui, Mohammad A. Al Jarallah, Gary Tse, Jeffrey Shi Kai Chan, Danish Iltaf Satti, Chloe Tsz Ching Hui, Yuxi Sun, Yan Hiu Athena Lee, Ying Liu, Govindan Vijayaraghavan, Ibrahim Al-Zakwani, Laura AlObaid
Ann Med Surg (Lond) 2024 Apr; 86(4): 1843–1849. Published online 2024 Feb 28. doi: 10.1097/MS9.0000000000001646
PMCID:
PMC10990347
ArticlePDF–405K
4.
Superoxide dismutases: marker in predicting reduced left ventricular ejection fraction in patients with type 2 diabetes and acute coronary syndrome
Xiu-Yun Jiang, Qing Chen, Xiao-Yu Chen, Qiu-Ying Sun, Fei Jing, Hai-Qing Zhang, Jin Xu, Xiao-Hong Li, Qing-Bo Guan
BMC Cardiovasc Disord. 2024; 24: 191. Published online 2024 Apr 3. doi: 10.1186/s12872-024-03867-2
PMCID:
PMC10988854
ArticlePDF–1.0M
5.
Perioperative Left Ventricular Assist Device Use in Patients With Reduced Ejection Fraction Reduces Cardiac Surgery-Associated Acute Kidney Injury
Ujjawal Kumar, Zain Khalpey
Cureus. 2024 Mar; 16(3): e57248. Published online 2024 Mar 30. doi: 10.7759/cureus.57248
PMCID:
PMC10982134
ArticlePDF–554K
6.
Light-Chain (AL) Cardiac Amyloidosis Presenting as Heart Failure With Reduced Ejection Fraction
Luis E Santiago, Ali Tariq Alvi, Veniamin Melnychuk, Philip Mesquita, Pallavi Aneja
Cureus. 2024 Feb; 16(2): e55271. Published online 2024 Feb 29. doi: 10.7759/cureus.55271
PMCID:
PMC10981542
ArticlePDF–1.8M
7.
Outcomes with guideline-directed medical therapy and cardiac implantable electronic device therapies for patients with heart failure with reduced ejection fraction
John L. Mignone, Kevin M. Alexander, Michael Dobbles, Kyle Eberst, Gregg C. Fonarow, Kenneth A. Ellenbogen
Heart Rhythm O2. 2024 Mar; 5(3): 168–173. Published online 2024 Jan 24. doi: 10.1016/j.hroo.2024.01.004
PMCID:
PMC10980920
ArticlePDF–628K
8.
Unlocking the potential of sacubitril/valsartan therapy in improving ECG and echocardiographic parameters in heart failure patients with reduced ejection fraction (HErEF)
Lamyaa Elsayed Allam, Ahmed Aly Abdelmotteleb, Hayam Mohamed Eldamanhoury, Hassan Shehata Hassan
Egypt Heart J. 2024 Dec; 76: 41. Published online 2024 Mar 28. doi: 10.1186/s43044-024-00468-4
PMCID:
PMC10978557
ArticlePDF–1.0M
9.
Moderate continuous or high intensity interval exercise in heart failure with reduced ejection fraction: Differences between ischemic and non-ischemic etiology
Martin Halle, Eva Prescott, Emeline M. Van Craenenbroeck, Paul Beckers, Vibeke Videm, Trine Karlsen, Patrick Feiereisen, Ephraim B. Winzer, Norman Mangner, Martin Snoer, Jeffrey W. Christle, Håvard Dalen, Asbjørn Støylen, Katrin Esefeld, Melanie Heitkamp, Bianca Spanier, Axel Linke, Øyvind Ellingsen, Charles Delagardelle, SMARTEX-HF Study Group
Am Heart J Plus. 2022 Oct; 22: 100202. Published online 2022 Sep 5. doi: 10.1016/j.ahjo.2022.100202
PMCID:
PMC10978420
ArticlePDF–404K
10.
Target heart rate in heart failure with reduced ejection fraction and atrial fibrillation: Goldilocks zone
Kerrick Hesse
Am Heart J Plus. 2022 Nov; 23: 100218. Published online 2022 Oct 17. doi: 10.1016/j.ahjo.2022.100218
PMCID:
PMC10978401
ArticlePDF–2.1M
11.
Higher C-Reactive Protein to Albumin Ratio Portends Long-Term Mortality in Patients with Chronic Heart Failure and Reduced Ejection Fraction
Veysel Ozan Tanık, Evliya Akdeniz, Tufan Çınar, Barış Şimşek, Duygu İnan, Ahmet Kıvrak, Yavuz Karabağ, Metin Çağdaş, Kamuran Kalkan, Can Yücel Karabay, Bülent Özlek
Medicina (Kaunas) 2024 Mar; 60(3): 441. Published online 2024 Mar 7. doi: 10.3390/medicina60030441
PMCID:
PMC10972301
ArticlePDF–824K
12.
Mitral Valve Surgery for Mitral Regurgitation Results in Reduced Left Ventricular Ejection Fraction in Barlow’s Disease as Compared with Fibro-Elastic Deficiency
Lobke L. Pype, Philippe B. Bertrand, Philippe Debonnaire, Sebastiaan Dhont, Boukje Hoekman, Bernard P. Paelinck, Dina De Bock, Hein Heidbuchel, Emeline M. Van Craenenbroeck, Caroline M. Van De Heyning
J Cardiovasc Dev Dis. 2024 Mar; 11(3): 71. Published online 2024 Feb 21. doi: 10.3390/jcdd11030071
PMCID:
PMC10970981
ArticlePDF–1.0M
13.
Beyond Quadruple Therapy and Current Therapeutic Strategies in Heart Failure with Reduced Ejection Fraction: Medical Therapies with Potential to Become Part of the Therapeutic Armamentarium
Christos Kourek, Alexandros Briasoulis, Adamantia Papamichail, Andrew Xanthopoulos, Elias Tsougos, Dimitrios Farmakis, Ioannis Paraskevaidis
Int J Mol Sci. 2024 Mar; 25(6): 3113. Published online 2024 Mar 7. doi: 10.3390/ijms25063113
PMCID:
PMC10969833
ArticlePDF–309K
14.
Exercise training and high‐sensitivity cardiac troponin‐I in patients with heart failure with reduced ejection fraction
Egil Riveland, Torstein Valborgland, Anastasia Ushakova, Øyvind Skadberg, Trine Karlsen, Torstein Hole, Asbjørn Støylen, Håvard Dalen, Vibeke Videm, Elias Koppen, Axel Linke, Charles Delagardelle, Emeline M. Van Craenenbroeck, Paul Beckers, Eva Prescott, Martin Halle, Torbjørn Omland, Øyvind Ellingsen, Alf Inge Larsen, the SMARTEX‐HF Study Group
ESC Heart Fail. 2024 Apr; 11(2): 1121–1132. Published online 2024 Jan 24. doi: 10.1002/ehf2.14674
PMCID:
PMC10966269
ArticlePDF–794K
15.
Circulating 3‐hydroxy butyrate predicts mortality in patients with chronic heart failure with reduced ejection fraction
Kristian Hylleberg Christensen, Roni R. Nielsen, Morten Schou, Ida Gustafsson, Anders Jorsal, Allan Flyvbjerg, Lise Tarnow, Hans Erik Bøtker, Caroline Kistorp, Mogens Johannsen, Niels Møller, Henrik Wiggers
ESC Heart Fail. 2024 Apr; 11(2): 837–845. Published online 2024 Jan 9. doi: 10.1002/ehf2.14476
PMCID:
PMC10966261
ArticlePDF–864K
16.
Role of vericiguat in management of patients with heart failure with reduced ejection fraction after worsening episode
Aleix Olivella, Luis Almenar‐Bonet, Pedro Moliner, Emmanuel Coloma, Antoni Martínez‐Rubio, Marco Paz Bermejo, Ramon Boixeda, German Cediel, Ana Belén Méndez Fernández, Lorenzo Facila Rubio
ESC Heart Fail. 2024 Apr; 11(2): 628–636. Published online 2023 Dec 29. doi: 10.1002/ehf2.14647
PMCID:
PMC10966234
ArticlePDF–834K
17.
Pressure overload is associated with right ventricular dyssynchrony in heart failure with reduced ejection fraction
Luca Monzo, Marek Tupy, Barry A. Borlaug, Adrian Reichenbach, Ivana Jurcova, Jan Benes, Lenka Mlateckova, Jiri Ters, Josef Kautzner, Vojtech Melenovsky
ESC Heart Fail. 2024 Apr; 11(2): 1097–1109. Published online 2024 Jan 23. doi: 10.1002/ehf2.14682
PMCID:
PMC10966231
ArticlePDF–899K
18.
Network meta-analysis comparing angiotensin receptor-neprilysin inhibitors, angiotensin-receptor blockers, and angiotensin-converting enzyme inhibitors in heart failure with reduced ejection fraction
Dae Yong Park, Seokyung An, Steve Attanasio, Neeraj Jolly, Saurabh Malhotra, Rami Doukky, Marc D. Samsky, Sounok Sen, Tariq Ahmad, Michael G. Nanna, Aviral Vij
Am J Cardiol. Author manuscript; available in PMC 2024 Mar 22.
Published in final edited form as: Am J Cardiol. 2023 Jan 15; 187: 84–92. Published online 2022 Nov 29. doi: 10.1016/j.amjcard.2022.10.026
PMCID:
PMC10958453
ArticlePDF–1.4M
19.
Reduced mitochondrial pyruvate carrier expression in hearts with heart failure and reduced ejection fraction patients: ischemic vs. non-ischemic origin
Paula Lopez-Vazquez, Mariana Fernandez-Caggiano, Eduardo Barge-Caballero, Gonzalo Barge-Caballero, David Couto-Mallon, Zulaika Grille-Cancela, Paula Blanco-Canosa, Maria J. Paniagua-Martin, Daniel Enriquez-Vazquez, Jose M. Vazquez-Rodriguez, Nieves Domenech, Maria G. Crespo-Leiro
Front Cardiovasc Med. 2024; 11: 1349417. Published online 2024 Mar 8. doi: 10.3389/fcvm.2024.1349417
PMCID:
PMC10957580
ArticlePDF–5.2M
20.
Prevalence and impact of sarcopenia in individuals with heart failure with reduced ejection fraction (the SARC-HF study): A prospective observational study protocol
Pablo Marino Corrêa Nascimento, Luiz Fernando Rodrigues Junior, Mauro Felippe Felix Mediano, Valéria Gonçalves da Silva, Bernardo Rangel Tura, Fabio César Sousa Nogueira, Gilberto Domont, Adriana Bastos Carvalho, Antônio Carlos Campos de Carvalho, Taís Hanae Kasai-Brunswick, Claudio Tinoco Mesquita, Humberto Villacorta Junior, Helena Cramer Veiga Rey
PLoS One. 2024; 19(3): e0300918. Published online 2024 Mar 21. doi: 10.1371/journal.pone.0300918
PMCID:
PMC10956824
ArticlePDF–1.0M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center